REVUE NEUROLOGIQUE

Scope & Guideline

Your Gateway to Rigorous Neurological Research

Introduction

Welcome to your portal for understanding REVUE NEUROLOGIQUE, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageFrench
ISSN0035-3787
PublisherMASSON EDITEUR
Support Open AccessNo
CountryFrance
TypeJournal
Convergefrom 1946 to 1947, from 1950 to 1961, from 1963 to 2024
AbbreviationREV NEUROL-FRANCE / Rev. Neurol.
Frequency10 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE

Aims and Scopes

The REVUE NEUROLOGIQUE is dedicated to advancing knowledge in the field of neurology, with a focus on clinical, epidemiological, and therapeutic aspects of neurological disorders. Its scope encompasses a wide range of topics, reflecting the complexity and diversity of neurological conditions and their management.
  1. Clinical Neurology:
    The journal emphasizes clinical research, presenting studies that evaluate diagnostic methods, treatment efficacy, and the management of various neurological disorders.
  2. Neurogenetics and Biomarkers:
    Research focusing on genetic factors and biomarkers associated with neurological diseases is a key area, enhancing our understanding of disease mechanisms and potential therapeutic targets.
  3. Neuroimaging and Neuropathology:
    The use of advanced imaging techniques and neuropathological studies to diagnose and understand neurological disorders is frequently explored, providing insights into disease progression and treatment outcomes.
  4. Neuropsychology and Cognitive Function:
    The journal publishes studies on the cognitive and psychological aspects of neurological conditions, examining how these disorders impact mental health and quality of life.
  5. Innovative Therapies and Interventions:
    A focus on novel treatment approaches, including pharmacological, surgical, and rehabilitative strategies, is evident, highlighting the journal's commitment to improving patient outcomes.
  6. Public Health and Epidemiology:
    The REVUE NEUROLOGIQUE also addresses the epidemiological aspects of neurological diseases, contributing to a better understanding of their prevalence, risk factors, and public health implications.
The REVUE NEUROLOGIQUE has increasingly focused on several emerging themes that reflect the current priorities and advancements in the field of neurology. These trends highlight the journal's responsiveness to new challenges and innovations in neurological research.
  1. Neuroimmunology and Autoimmune Disorders:
    An increasing number of studies focus on neuroimmunological conditions, such as autoimmune encephalitis and myasthenia gravis, reflecting a growing interest in the interplay between the immune system and neurological health.
  2. Neurodegeneration and Aging:
    Research on neurodegenerative diseases, particularly in the context of aging populations, is on the rise, emphasizing the need for effective management strategies and interventions.
  3. Digital Health and Telemedicine:
    The COVID-19 pandemic has accelerated the adoption of digital health technologies and telemedicine in neurology, leading to a surge in studies evaluating their effectiveness and implementation.
  4. Neurotechnology and Therapeutic Innovations:
    There is a notable trend towards exploring innovative neurotechnological interventions, including neuromodulation techniques and gene therapies, aimed at improving patient outcomes.
  5. Psychiatric Comorbidities in Neurological Disorders:
    Research examining the relationship between neurological conditions and psychiatric disorders, such as depression and anxiety, is gaining traction, reflecting a holistic approach to patient care.

Declining or Waning

While the REVUE NEUROLOGIQUE continues to publish a wide array of topics in neurology, certain themes have become less prominent in recent years, reflecting shifts in research priorities and emerging areas of interest.
  1. Classical Neurological Syndromes:
    There has been a noticeable decline in publications focusing on classical neurological syndromes that were once staples of neurology literature, possibly due to a shift towards more contemporary issues such as neurogenetics and advanced imaging.
  2. Historical and Biographical Studies:
    Research centered on the historical aspects of neurology and biographical studies of notable figures in the field has decreased, as the focus shifts towards current clinical and experimental findings.
  3. General Neurological Education:
    Papers solely focused on general education in neurology or basic clinical practices are becoming less common, indicating a trend towards more specialized and research-driven content.
  4. Traditional Pharmacological Approaches:
    There appears to be a waning interest in traditional pharmacological approaches, as newer therapeutic strategies and personalized medicine gain prominence in the field.

Similar Journals

NEUROLOGIA

Connecting Global Minds in the Pursuit of Neurological Excellence
Publisher: ELSEVIER ESPANA SLUISSN: 0213-4853Frequency: 9 issues/year

NEUROLOGIA, an esteemed journal published by ELSEVIER ESPANA SLU, stands at the forefront of the field of neurology, with a dedicated focus on innovative research and clinical practice since its inception in 1973. As an Open Access journal since 2017, it champions the dissemination of knowledge, allowing researchers, professionals, and students alike to access cutting-edge findings in neurology without barriers. With an impressive Scopus rank of #115 in the clinical neurology category, placing it in the 71st percentile, NEUROLOGIA is categorized as Q3 in both general medicine and clinical neurology, reflecting its impact and relevance in a rapidly evolving field. Based in Barcelona, Spain, the journal's commitment to advancing understanding of neurological conditions is underscored by its rigorous peer-review process and engagement with a global audience. As it continues to publish vital research that shapes clinical practices and informs policy, NEUROLOGIA remains an integral resource for those striving to improve outcomes in neurology.

JAMA Neurology

Advancing Neurological Insights for Tomorrow's Treatments
Publisher: AMER MEDICAL ASSOCISSN: 2168-6149Frequency: 12 issues/year

JAMA Neurology is a leading peer-reviewed journal published by the American Medical Association, focused on advancing the understanding and treatment of neurological disorders. With an impressive impact factor and ranked in the 99th percentile among clinical neurology journals, this publication is recognized as Q1 in its category for 2023, highlighting its significance in the field. Since its inception, the journal has provided a platform for high-quality research, clinical trials, and reviews that inform both clinicians and researchers. Operating from its headquarters in Chicago, Illinois, JAMA Neurology offers rich insights into the latest advancements in neurology, featuring articles that span a wide range of topics including neurodegenerative diseases, stroke, epilepsy, and neurocritical care. Researchers and professionals are encouraged to access the journal’s content freely, as it employs open access options to promote the dissemination of critical knowledge. As a critical resource in the field of neurology, JAMA Neurology is essential for anyone involved in this dynamic and rapidly evolving specialty.

Multiple Sclerosis and Related Disorders

Connecting researchers and practitioners in neurology.
Publisher: ELSEVIER SCI LTDISSN: 2211-0348Frequency: 6 issues/year

Multiple Sclerosis and Related Disorders, published by Elsevier Science Ltd, is a leading journal that serves as a vital resource in the field of neurology, particularly focused on multiple sclerosis and its associated conditions. This esteemed journal, which holds a Q1 ranking in Medicine (miscellaneous) and Q2 ranking in both Neurology and Clinical Neurology, delivers high-impact research findings and clinical insights crucial for advancing the understanding and management of multiple sclerosis. With an ISSN of 2211-0348 and an E-ISSN of 2211-0356, it provides valuable content from 2012 to 2024 aimed at researchers, healthcare professionals, and students dedicated to improving patient outcomes and fostering innovative strategies in treatment. Additionally, the journal's presence in the Scopus rankings highlights its relevance and influence in the academic community, ranking 121 out of 400 in Clinical Neurology and 59 out of 192 in Neuroscience. This comprehensive platform encourages the dissemination of cutting-edge knowledge and clinical practices, making it an essential tool for those committed to the field of neurology and related research.

Acta Epileptologica

Unveiling the latest trends in epilepsy treatment.
Publisher: SPRINGERNATUREISSN: 2096-9384Frequency: 1 issue/year

Acta Epileptologica is a prominent open-access journal published by SPRINGERNATURE, dedicated to advancing research in the fields of neurology and clinical neurology. With its ISSN 2096-9384 and E-ISSN 2524-4434, this journal has established itself as a key resource for researchers and practitioners worldwide, particularly since its transition to open access in 2019. Based in the United Kingdom, Acta Epileptologica aims to disseminate high-quality research and foster scholarly collaboration, as evidenced by its consistent Q3 ranking in both neurology and clinical neurology categories as of 2023. Although currently positioned in the lower percentiles on Scopus, the journal plays a critical role in exploring emerging trends and novel therapeutic approaches in epilepsy research, making it an essential platform for academics, healthcare professionals, and students deeply invested in the evolving landscape of neurological disorders.

Neurology International

Elevating Neurology Through Open Access Scholarship
Publisher: MDPIISSN: 2035-8377Frequency: 4 issues/year

Neurology International is a prestigious open-access journal published by MDPI that has been making significant contributions to the field of neurology since its establishment in 2009. With its ISSN 2035-8377, this journal is committed to disseminating high-quality, peer-reviewed research that addresses a wide range of clinical topics in neurology. Operating out of Basel, Switzerland, the journal holds a respectable Q2 ranking in the clinical neurology category as of 2023, indicating its influence and dedication to advancing scientific knowledge. Researchers and practitioners alike will find value in its comprehensive articles, which are readily accessible to a global audience, facilitating the sharing of innovative findings and clinical practices. As it converges towards 2024, Neurology International continues to provide a vital platform for scholarly discourse, aiming to improve patient outcomes and enhance our understanding of neurological disorders.

Postepy Psychiatrii i Neurologii

Bridging Gaps in Psychiatric and Neurological Science
Publisher: TERMEDIA PUBLISHING HOUSE LTDISSN: 1230-2813Frequency: 4 issues/year

Postepy Psychiatrii i Neurologii is a prominent academic journal dedicated to advancing the fields of psychiatry and neurology. Published by TERMEDIA PUBLISHING HOUSE LTD in Poland, this journal has become an essential resource for researchers, clinicians, and students, fostering interdisciplinary communication and dialogue. With a record of publication extending from 2007 to 2024, it has carved a niche in important subfields, reflected in its category quartile rankings: Q3 in Clinical Psychology and Q4 in Neurology, Psychiatry, and Mental Health for 2023. Though it currently does not offer open access, the journal maintains a commitment to high-quality research dissemination. As a vital platform for sharing innovative findings and clinical practices, Postepy Psychiatrii i Neurologii contributes significantly to the global discourse on mental health and neurological disorders, making it an indispensable tool for academics and practitioners alike.

Multiple Sclerosis International

Advancing knowledge, transforming lives in MS research.
Publisher: HINDAWI LTDISSN: 2090-2654Frequency:

Multiple Sclerosis International is a leading open-access journal dedicated to advancing the scientific understanding of multiple sclerosis (MS) and related neurological disorders. Published by HINDAWI LTD since 2010, this journal serves as a vital resource for researchers, clinicians, and students alike, providing a platform for high-quality peer-reviewed articles that cover a diverse range of topics, including epidemiology, treatment strategies, and the latest advancements in MS research. With its commitment to open access, Multiple Sclerosis International ensures that critical findings are readily available to the global community, fostering collaborative efforts to improve patient outcomes and advance therapeutic approaches. The journal not only enhances scholarly discourse in the field but also significantly impacts clinical practices by presenting cutting-edge research and insights.

CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE

Fostering Innovation in Neurological Sciences
Publisher: CZECH MEDICAL SOCISSN: 1210-7859Frequency: 6 issues/year

CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE is a prominent scientific journal focusing on the fields of neurology and neurosurgery, published by the esteemed Czech Medical Society. Since its inception in 1973, the journal has aimed to disseminate significant research and advancements in clinical neurology and surgery, contributing to the body of knowledge for professionals and researchers in these fields. Operating under a non-open access model, it maintains a dedicated readership interested in valuable insights from the latest studies and clinical practices. The journal is currently classified in the Q4 category in both Neurology (Clinical) and Surgery, reflecting its ongoing efforts to provide a platform for impactful research, despite being ranked in the lower percentiles within Scopus. Based in Prague, Czech Republic, this journal not only serves as a repository of clinical findings but also encourages collaboration and scholarly dialogue among neurologists and neurosurgeons, driving the field towards further innovations in patient care. With coverage extending from 1973 to 2024, it stands as a key resource for those committed to advancing neurological and surgical sciences.

Revista Mexicana de Neurociencia

Bridging Clinical Practice and Experimental Neuroscience
Publisher: ACAD MEXICANA NEUROLOGIAISSN: 1665-5044Frequency: 6 issues/year

The Revista Mexicana de Neurociencia, published by the ACAD MEXICANA NEUROLOGIA, serves as a pivotal platform for the dissemination of research within the field of neurology and neuroscience. Although it was active from 2008 to 2014 and is no longer covered in Scopus, the journal still holds a significant place in the academic community, addressing critical topics relevant to both clinical and experimental neurology. With an emphasis on advancing knowledge in neuropsychology and public health, this journal targets researchers, professionals, and students alike, fostering an interdisciplinary dialogue that can enhance the understanding of neurological conditions within Mexico and beyond. As it stands, the journal is not open access, which may present challenges for accessibility, yet its affiliation with recognized academic standards underlines its commitment to quality research. This platform once provided insights that can inform practice and stimulate innovative approaches in the management of neurological disorders, underscoring its importance in the evolving landscape of neuroscience.

ACTA NEUROLOGICA BELGICA

Exploring the Depths of Neurological Research.
Publisher: SPRINGER HEIDELBERGISSN: 0300-9009Frequency: 4 issues/year

ACTA NEUROLOGICA BELGICA is a leading academic journal published by Springer Heidelberg, dedicated to advancing the field of neurology and medicine. With an ISSN of 0300-9009 and E-ISSN 2240-2993, this journal has been a vital resource since its inception, contributing significantly to neurological research and clinical practice. It holds a respectable impact factor with categories spanning from Q2 in Medicine (miscellaneous) to Q3 in Neurology (clinical) as of 2023, indicating its prominence in the scientific community. The journal's extensive coverage since 1959 enhances its historical relevance, while its ongoing publication until 2024 ensures the latest developments are readily accessible. Researchers and practitioners can benefit from its rigorous peer-reviewed articles, which are crucial for staying current in this rapidly evolving discipline. As a scholarly platform, ACTA NEUROLOGICA BELGICA plays a pivotal role in disseminating knowledge and fostering innovation in neurology, making it a must-read for professionals, students, and anyone involved in the field.